4//SEC Filing
Shendelman Shoshana 4
Accession 0001096906-24-000497
CIK 0001697532other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:12 PM ET
Size
10.1 KB
Accession
0001096906-24-000497
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2024-03-14$5.39/sh−318,573$1,717,108→ 3,817,814 total
Holdings
- 88,397(indirect: See footnote)
Common Stock
- 1,750,000(indirect: See footnote)
Common Stock
- 1,492,094(indirect: See footnote)
Common Stock
- 709,720(indirect: See footnote)
Common Stock
- 290,280(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.37 to $5.795, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Through a grantor retained annuity trust.
- [F4]Through a family trust controlled by the reporting person's spouse.
- [F5]Through the reporting person's spouse.
- [F6]Through a family trust controlled by the reporting person.
- [F7]Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Documents
Issuer
Applied Therapeutics, Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775490
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:12 PM ET
- Size
- 10.1 KB